Related Experiment Video
Updated: Nov 10, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with
Pasquale Esposito1,2, Leda Cipriani1, Daniela Verzola1
1Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
Insights
In hemodialysis patients with COVID-19, inflammation is not sustained. Expanded hemodialysis (HDx) showed a decrease in interleukin-10 (IL-10) levels, unlike standard treatment. Therapeutic modulation of inflammation is not a viable target in this patient group.
Area of Science:
- Nephrology
- Immunology
- Infectious Diseases
Background:
- Uncontrolled inflammation is implicated in COVID-19 pathogenesis.
- Hemodialysis (HD) patients represent a vulnerable population for severe COVID-19 outcomes.
- Understanding inflammatory marker dynamics in HD patients with COVID-19 is crucial.
Purpose of the Study:
- To investigate the time trend of inflammatory markers in maintenance HD patients with COVID-19.
- To compare the effects of expanded hemodialysis (HDx) versus standard protein-leaking dialyzer (PLD) treatment on inflammatory markers.
- To determine if modulating inflammation is a suitable therapeutic target in this population.
Main Methods:
- Prospective study involving 31 maintenance HD patients with COVID-19.
- Randomization to either HDx (medium cut-off membrane) or PLD treatment.
- Measurement of circulating levels of IL-6, IL-8, IL-10, sTLR4, and IFN-γ at diagnosis, and at one and two weeks post-diagnosis.
Main Results:
- COVID-19 patients exhibited lymphopenia and elevated ferritin and lactate dehydrogenase compared to non-infected HD patients.
- COVID-19 patients presented higher baseline IL-10 levels.
- While IL-8 decreased in both HDx and PLD groups, IL-10 reduction was observed only in the HDx group after a single treatment. No significant sustained differences in cytokine levels were found between HDx and PLD groups over the study period. No correlations between cytokine levels and clinical outcomes were identified.
Conclusions:
- COVID-19 in maintenance HD patients is not characterized by a sustained inflammatory response.
- The observed inflammatory profile suggests that therapeutic modulation of inflammation may not be an effective strategy for COVID-19 in this specific patient cohort.
- Expanded hemodialysis (HDx) may influence specific cytokine dynamics, but overall inflammatory modulation is not a primary therapeutic target.
Abstract:
Uncontrolled inflammation plays a relevant role in the pathogenesis of coronavirus disease-19 (COVID-19). Here, we studied the time trend of inflammatory markers in a population of hemodialysis (HD) patients affected by COVID-19, undergoing two different dialysis approaches. In a prospective study, thirty-one maintenance HD patients with COVID-19 were randomized to expanded HD (HDx), performed using a medium cut-off membrane, or standard treatment using a protein-leaking dialyzer (PLD). Circulating levels of interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), soluble TLR4 (sTLR4), and interferon-gamma (IFN-γ), were collected at diagnosis, and one and two weeks after. Compared with 14 non-infected HD patients, COVID-19 patients showed lymphopenia and higher ferritin and lactate dehydrogenase levels. Moreover, COVID-19 patients had higher levels of IL-10 (15.2 (12.5) vs. 1.2 (1.4) pg/mL, p = 0.02). Twenty-nine patients were randomized to HDx (n = 15) or PLD (n = 14). After a single treatment, IL-8 showed a significant reduction in both groups, whereas IL-10 decreased only in HDx. All over the study, there were no significant modifications in circulating cytokine levels between the two groups, except for a parallel increase of IL-8 and IL-10 at one week control in the HDx group. No correlations were found between cytokine levels and clinical outcomes. In maintenance HD patients, COVID-19 is not related to a sustained inflammatory response. Therefore, modulation of inflammation seems not to be a suitable therapeutic target in this specific population.
Related Concept Videos
Hemodialysis III: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care

